Generics & Biosimilars | Association for Accessible Medicines
GRx+Biosims - No-cost FDA workshop limited to first 100 who sign up. Act now!
Learn More
Close
  • ""
    The Case for Competition
    Now available: AAM's full 2019 Generic Drug & Biosimilars Access & Savings in the U.S. Report
    Read Full Report
  • ""
    Happy Birthday, Generic Prescription Drugs!
    We're celebrating 35 years of competition and $2 trillion in savings from generics in the last 10 years. #hb2generics
    Read Blog
  • Access Denied: Why New Generics Are Not Reaching America's Seniors
    New White Paper: Access Denied
    AAM's "Access Denied" white paper highlights new data on the treatment of generic medicines in Medicare Part D, resulting in patients paying more for their medicines even when lower-priced FDA-approved generics and biosimilars are available.
    Read Press Release
  • ""
    More Speakers + Opportunities
    It's shaping up to be the best lineup ever at GRx+Biosims 2019 with more than 40 influential speakers you don’t want to miss.
    View Agenda
  • ""
    How Much Did Your State Save?
    Take a deeper look at state-by-state generic drug savings from the 2019 Generic Drug and Biosimilars Access & Savings in the U.S. report.
    Read Blog
  • NAFTA 2.0: Obstacles to More Affordable Medicines for Americans
    NAFTA 2.0: Obstacles to More Affordable Medicines
    The U.S.-Mexico-Canada Agreement (USMCA) or "NAFTA 2.0" contains obstacles to more affordable meds for Americans. There is still time to #FixUSMCA to put America’s patient first!
    View Infographic

Working to leave a positive impact on...

Industry Industry We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More
People People We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More
Policy Policy We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Who We Are

Recent Updates

Association for Accessible Medicines

601 New Jersey Ave NW, Suite 850
Washington DC 20001

 

202.249.7100
info@accessiblemeds.org

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.